SALT LAKE CITY, Nov. 23, 2016 /PRNewswire/ -- USANA Health
Sciences, Inc. (NYSE: USNA) today announced a CEO transition plan.
Dave Wentz has made the personal
decision to step down as Co-CEO and a member of the Board of
Directors of the Company. The Board of Directors has appointed
current Co-CEO, Kevin Guest, as CEO
of the Company. The Company will no longer utilize a Co-CEO
management structure. The USANA Board of Directors now consists of
six directors, four of whom are independent.
Commenting on his transition, Mr. Wentz said, "I am grateful for
my long tenure with USANA and am proud of what we have accomplished
over the past 24 years. USANA has always been, and will remain, a
positive influence for so many lives, including my own, and I am
confident in the company's future under Kevin's leadership. I am
looking forward to spending more time with my family and continuing
to advocate for the direct sales industry as Chairman of the Direct
Selling Education Foundation."
Gilbert Fuller, Chairman of the
Governance, Risk and Nominating Committee of the Board of
Directors, said, "Dave has made an incredible contribution to our
organization over the past two decades. He has skillfully led the
Company to multiple years of record sales and customer growth and
helped the Company navigate both anticipated and unanticipated
challenges. We are grateful for his dedication and hard work in the
many roles he has held with USANA and wish him all the best going
forward."
Commenting on the appointment of Mr. Guest as CEO, Dr.
Myron Wentz, Chairman of the Board,
noted, "We are pleased to name Kevin
Guest as CEO of USANA. Kevin has led USANA in a variety of
roles for more than 20 years, including President and most recently
as Co-CEO. In each role, Kevin has demonstrated sound
leadership, integrity and judgment. Perhaps most importantly, Kevin
has earned the trust, respect and admiration of countless USANA
Associates, customers and employees around the world as he has
served them. On behalf of the Board, we are grateful to Kevin for
his great commitment and leadership to USANA in its mission to
improve the health and nutrition of individuals and families around
the world."
Kevin Guest commented, "I am
honored by the trust and confidence the Board of Directors has
placed in me to lead USANA going forward. Dave and I have worked
side by side to achieve many goals over the years, and I have the
utmost respect for him. I also have complete confidence in, and
respect for, the leadership team we have in place at USANA. Our
team has talent and experience in each of the key leadership
positions and is committed to USANA's mission. As demonstrated by
the Board's recent decision to split the stock, we are confident
that the strategies we have in place will help USANA achieve its
long-term growth potential."
About USANA
USANA (NYSE: USNA) develops and manufactures high-quality
nutritional supplements, healthy foods and personal care products
that are sold directly to Associates and Preferred Customers
throughout the United States,
Canada, Australia, New
Zealand, Hong Kong, China,
Japan, Taiwan, South
Korea, Singapore,
Mexico, Malaysia, the
Philippines, the
Netherlands, the United
Kingdom, Thailand,
France, Belgium, Colombia and Indonesia. More information
on USANA can be found at usana.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including global economic conditions generally, reliance upon our
network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion.
The contents of this release should be considered in conjunction
with the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission.
Investors
contact:
|
Joshua
Foukas
|
|
Investor
Relations
|
|
(801)
954-7823
|
|
investor.relations@us.usana.com
|
|
|
Media
contact:
|
Ashley
Collins
|
|
Public
Relations
|
|
(801)
954-7629
|
|
media@us.usana.com
|
Logo -
http://photos.prnewswire.com/prnh/20120807/LA53885LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/usana-health-sciences-announces-ceo-transition-plan-and-appoints-kevin-guest-chief-executive-officer-300367791.html
SOURCE USANA Health Sciences, Inc.